A. “You're right. You don't need these medications since you aren't having any atrial fibrillation symptoms.” B. “Unfortunately, I'm unable to tell you if you should take these medications or not. Please reach out to your physician.” C. “Yes, you should take these medications because you don't want to have a stroke. Luckily, atrial fibrillation has not been found to increase risk of death.” D. “Atrial fibrillation has many complications if left untreated, which include stroke and heart failure. It's very important that you take these medications, as they can prevent these complications from occurring.” E. Unsure

A. All patients over the age of 50 years should be screened by use of a 12-lead electrocardiogram (ECG) B. All patients with stroke risk factors should be screened by use of a wearable patch monitor C. There is currently not enough evidence to evaluate the benefits or harms of screening asymptomatic patients D. All patients regardless of age should utilize smartwatch technology as a screening tool E. Unsure

A. Apixaban 5 mg BID B. Dabigatran 150 mg BID C. Edoxaban 60 mg daily D. Rivaroxaban 10 mg daily E. Unsure

A. CKD 3 with SCr = 1.0 (CrCl = 56 mL/min) B. Use of a rolling walker for stability when walking C. Body mass index (BMI) of 29 (weight 77 kg, height 64 inches) D. Diltiazem ER 240 mg once daily is also on the discharge medication list E. Unsure

A. Discuss programs such as manufacturer patient assistance programs or “Extra Help” from Medicare that will reduce her medication cost B. Discuss the factors included in a shared decision-making tool to aid her understanding of her stroke risk due to AF regardless of symptoms C. Discuss aspirin as a good alternative to oral anticoagulants to reduce stroke risk in AF D. Advise her that she should utilize guideline recommended screening tools such as a wearable patch monitor to assess AF status E. Unsure